Research IDs new target for treating neuropathic pain | Research suggests nanobodies may reduce pain | Analysis does not support NIBS for migraine therapy
November 30, 2016
News for the pain professional
Pain Research News
Research IDs new target for treating neuropathic pain
Research suggests the compound ZD7288 could be developed as an analgesic to treat peripheral neuropathic pain. Researchers are seeking treatments with fewer side effects than sodium channel blockers. (11/28) 
LinkedIn Twitter Facebook Google+ Email
Research suggests nanobodies may reduce pain
Nanobodies may block inflammation and reduce pain, according to data from a study of mice, researchers reported in the journal Science Translational Medicine. Tests on human blood showed nanobodies were more effective at preventing release of an inflammatory molecule than similar small-molecule drug candidates. (11/23) 
LinkedIn Twitter Facebook Google+ Email
The Truth about Cloud Security
72% of businesses are using the cloud. 56% said they are still figuring out exactly where they can use the cloud more. Why would so many businesses already trust these services with their own and their clients' most sensitive data? While security risks are real, the cloud is also more secure than you think. Read this eBook to learn more
Treatment News
Analysis does not support NIBS for migraine therapy
An analysis of data from eight studies did not support use of noninvasive brain stimulation to prevent or treat migraine, researchers reported in the journal Headache. Compared with a sham treatment, NIBS was not significantly better at controlling migraine pain, reducing frequency or reducing the need for pain medication.
MedPage Today (free registration) (11/29) 
LinkedIn Twitter Facebook Google+ Email
Opioids may delay wound healing
A study of 450 patients with chronic wounds found a link between dosages of opioid pain medications and the rate of healing as measured by the overall surface area of the wound. The study appears in Wound Repair and Regeneration.
Clinical Innovation + Technology online (11/23) 
LinkedIn Twitter Facebook Google+ Email
Opioid drugs no better than NSAIDs for post-accident pain
A study of 948 people who had been in auto wrecks found opioid drugs were no better than nonsteroidal anti-inflammatory drugs. The study in the journal Pain found the risk of persistent pain was similar for patients taking opioids or NSAIDs, but those prescribed opioids were 17.5% more likely to still be taking them after six weeks.
HealthDay News (11/28) 
LinkedIn Twitter Facebook Google+ Email
Other News
Why Platform Matters When Choosing an ERP System
In order to survive, grow, and compete in the digital age, organizations need an ERP that is highly flexible and able to adapt. So, what are the tough platform questions you should ask yourself when shopping for an ERP?
Download the report to find out!
Policy & Trends
States restrict Medicaid coverage of opioid painkillers
Forty-six Medicaid programs cap prescriptions for opioid pain drugs, 45 require prior authorization, 42 require proof of medical need and 32 have step-therapy rules.
STAT (11/23) 
LinkedIn Twitter Facebook Google+ Email
Other News
APS News
Register for the 2017 Annual Scientific Meeting!
The 2017 Annual Scientific Meeting brings together science and innovation. Share your ideas and connect with your pain peers in Pittsburgh! The APS Annual Scientific Meeting will be held May 17-20, 2017, at the David L. Lawrence Convention Center. Register early and save. Learn more.
LinkedIn Twitter Facebook Google+ Email
Rita Allen Foundation Award in Pain
The Rita Allen Foundation and APS together may award two grants in the amount of $50,000 annually, for a period of up to 3 years to those research proposals demonstrating the greatest merit and potential for success. Eligible candidates will have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in basic science research in pain. Applications can be submitted to the grants portal until Jan. 16, 2017. Learn more.
LinkedIn Twitter Facebook Google+ Email
Concentrate all your thoughts upon the work at hand. The sun's rays do not burn until brought to a focus.
Alexander Graham Bell,
scientist and inventor
LinkedIn Twitter Facebook Google+ Email
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information